RNA processing regulation in neuronal integrity. However, a comprehensive protein-RNA interaction map for TDP-43 and identification of post-transcriptional events that may be crucial for neuronal survival remain to be established.
Amyotrophic lateral sclerosis (ALS) is an adult-onset disorder in which premature loss of motor neurons leads to fatal paralysis. Most cases of ALS are sporadic, with only 10% of affected individuals having a familial history. A breakthrough in understanding ALS pathogenesis was the discovery that TDP-43, which in the normal setting is primarily nuclear, mislocalizes and forms neuronal and glial cytoplasmic aggregates in ALS 1,2 , frontotemporal lobar degeneration (FTLD), and in Alzheimer's and Parkinson's diseases (reviewed in ref. 3) . Dominant mutations in TDP-43 were subsequently identified as being causative in sporadic and familial ALS cases and in rare individuals with FTLD [4] [5] [6] [7] . At present, it is unresolved as to whether neurodegeneration is a result of a loss of TDP-43 function or a gain of toxic property or a combination of the two. However, a notable feature of TDP-43 pathology is TDP-43 nuclear clearance in neurons containing cytoplasmic aggregates, consistent with pathogenesis being driven, at least in part, by a loss of TDP-43 nuclear function 1, 7 .
Several lines of evidence suggest an involvement of TDP-43 in multiple steps of RNA metabolism, including transcription, splicing or transport of mRNA 3 , as well as microRNA metabolism 8 . Misregulation of RNA processing has been described in a growing number of neurological diseases 9 . The recognition of TDP-43's role in neurodegeneration and the recent identification of ALS-causing mutations in FUS/TLS 10, 11 , another RNA/DNA binding protein, has reinforced a crucial role for We used cross-linking and immunoprecipitation coupled with high-throughput sequencing to identify binding sites in 6,304 genes as the brain RNA targets for TDP-43, an RNA binding protein that, when mutated, causes amyotrophic lateral sclerosis. Massively parallel sequencing and splicing-sensitive junction arrays revealed that levels of 601 mRNAs were changed (including Fus (Tls), progranulin and other transcripts encoding neurodegenerative disease-associated proteins) and 965 altered splicing events were detected (including in sortilin, the receptor for progranulin) following depletion of TDP-43 from mouse adult brain with antisense oligonucleotides. RNAs whose levels were most depleted by reduction in TDP-43 were derived from genes with very long introns and that encode proteins involved in synaptic activity. Lastly, we found that TDP-43 autoregulates its synthesis, in part by directly binding and enhancing splicing of an intron in the 3′ untranslated region of its own transcript, thereby triggering nonsense-mediated RNA degradation. a r t i c l e s identify TDP-43-binding sites from clusters of sequence reads (Fig. 1b) , with a conservative threshold (the number of reads mapped to a cluster had to exceed the expected number by chance at P < 0.01). This stringent definition will miss some true binding sites, but was intentionally chosen to identify the strongest bound sites while minimizing false positives. Indeed, additional probable binding sites could be identified by inspection of reads mapped to specific RNAs (see Fig. 1c ). Moreover, similarly defined clusters from the low mobility complexes (Supplementary Fig. 1b) showed a 92% overlap with those from the monomeric complexes (Fig. 1a) , consistent with the reduced mobility complexes comprising multiple TDP-43s (or other RNA-binding proteins) bound to a single RNA.
Genome-wide comparison of our replicate experiments revealed ( Supplementary Fig. 1c ) that the vast majority (90%) of TDP-43-binding sites in experiment 1 overlapped with those in experiment 2 (compared with an overlap of only 8% (P ≈ 0, Z = 570) when clusters were randomly distributed across the length of the pre-mRNAs containing them). Combining the mapped sequences yielded 39,961 clusters, representing binding sites of TDP-43 in 6,304 annotated protein-coding genes, approximately 30% of the murine transcriptome (Fig. 1d) . We computationally sampled reads (in 10% intervals) from the CLIP sequences and found a clear logarithmic relationship ( Supplementary  Fig. 1d ), from which we calculated that our current dataset contains ~84% of all TDP-43 RNA targets in the mouse brain. Comparison with the mRNA targets identified from primary rat neuronal cells 18 by RNA
RESULTS

Protein-RNA interaction map of TDP-43 in mouse brain
We used CLIP-seq to identify in vivo RNA targets of TDP-43 in adult mouse brain (Supplementary Fig. 1a) . After ultraviolet irradiation to stabilize in vivo protein-RNA interactions, we immunoprecipitated TDP-43 with a monoclonal antibody 16 that had a higher immunoprecipitation efficiency than any of the commercial antibodies tested (Supplementary Fig. 1b) . Complexes representing the expected molecular weight of a single molecule of TDP-43 bound to its target RNAs were excised (Fig. 1a) and sequenced. We also observed lower mobility protein-RNA complexes whose abundance was reduced by increased nuclease digestion. Immunoblotting of the same immunoprecipitated samples before radioactive labeling of the target RNAs revealed that TDP-43 protein was a component of both the ~43-kDa complex and more slowly migrating complexes (Fig. 1a) .
We performed two independent experiments and obtained 5,341,577 and 12,009,500 36-bp sequence reads. Mapped reads of both experiments were predominantly in protein-coding genes, with ~97% of them oriented in the direction of transcription, confirming little DNA contamination. The positions of mapped reads from both experiments were highly consistent, as exemplified by TDP-43 binding on the semaphorin 3F transcript (Fig. 1b) .
We used a cluster-finding algorithm with gene-specific thresholds that accounted for pre-mRNA length and variable expression levels 15, 17 a r t i c l e s intronic clusters being >2 kb from the nearest exon-intron boundary (Fig. 1f) . This number rose to 82% for clusters >500 bases from the nearest exon-intron boundary (Supplementary Fig. 2b ). Such distal intronic binding is in sharp contrast with published RNA-binding maps for tissue-specific RNA binding proteins involved in alternative splicing, such as Nova or Fox2 14, 15 . The same analysis on published data in mouse brain for the Argonaute proteins 17, 21 , which are recruited by microRNAs to the 3′ ends of genes in metazoans 17, 21 , showed a substantially different pattern of binding. Only 24% (or 30%) of Argonaute clusters resided within 2 kb (or 500 bases) of the nearest exon-intron boundary, whereas 28% were in 3′ untranslated regions (3′ UTRs) ( Fig. 1f and Supplementary Fig. 2b ). This prominent concentration of Argonaute binding near 3′ ends is in stark contrast with the uniform distribution of TDP-43-binding sites across the length of pre-mRNAs (Supplementary Fig. 2c ).
RNAs altered after in vivo TDP-43 depletion in mouse brain
To identify the contribution of TDP-43 in maintaining levels and splicing patterns of RNAs, we injected two antisense oligonucleotides (ASOs) directed against TDP-43 and a control ASO with no target in the mouse genome into the striatum of normal adult mice (Fig. 2a) .
Striatum is a well-defined structure that is amenable to accurate dissection and isolation, with TDP-43 expression levels being comparable to other brain regions. Stereotactic injections of ASOs that target TDP-43, control ASO or saline were performed in three groups of age-and sexmatched adult C57BL/6 mice and were tolerated with minimal effects immunoprecipitation (RIP, an approach with the serious caveat that the absence of cross-linking allows re-association of RNAs and RNAbinding proteins after cell lysis, as previously documented 19 ) revealed 2,672 of the genes with CLIP-seq clusters in common. As expected from our CLIP-seq analysis in whole brain, we found strong representation of neuronal (see below) and glial mRNA targets, including glutamate transporter 1 (Glt1), myelin-associated glycoprotein (Mag) and myelin oligodendrocyte glycoprotein (Mog).
TDP-43 binds GU-rich distal intronic sites Sequence motifs enriched in TDP-43-binding sites were determined by comparing sequences in clusters with randomly selected regions of similar sizes in the same protein-coding genes. Z score statistics revealed that the most significantly enriched hexamers consisted of GU-repeats (Z > 450), consistent with published in vitro results 20 , or a GU-rich motif interrupted by a single adenine (Z = 137-158) (Fig. 1e) . The majority (57%) of clusters contained at least four GUGU elements, as compared with only 9% when equally sized clusters were randomly placed in the same pre-mRNAs (Fig. 1e) . Furthermore, the number of GUGU tetramers correlated with the strength of binding, as estimated by the relative number of reads in each cluster per gene compared with all clusters in other genes ( Supplementary  Fig. 2a ). Nevertheless, genome-wide analysis revealed that GU-rich repeats were neither necessary nor sufficient to specify a TDP-43-binding site. One example is the left-most binding site in neurexin 3 ( Fig. 1c) , which does not have a GU motif, whereas a GU-rich motif 2-kb upstream of it was not bound by TDP-43. In fact, only ~3% of all transcribed 300 nucleotide stretches containing more than three GUGU tetramers contained TDP-43 clusters by CLIP-seq, indicating that TDP-43 target genes cannot be identified by simply scanning nucleotide sequences for GU-rich regions. Although the vast majority (93%) of TDP-43 sites were in introns, we identified a binding preference of TDP-43 with most (63%) 
a r t i c l e s
Of the RNAs containing TDP-43 clusters, 96% were unaffected by TDP-43 depletion, suggesting either that other RNA-binding proteins compensate for TDP-43 loss or that the remaining 20% of TDP-43 protein suffices to regulate these transcripts. For the 239 RNAs downregulated after TDP-43 depletion, a striking enrichment of multiple TDP-43 binding sites was observed (Fig. 3 ). In fact, the 100 most downregulated genes contained an average of ~37 TDP-43-binding sites per pre-mRNA and 12 genes had more than 100 clusters ( Fig. 3a and Supplementary Table 2 ). We did not observe this bias for multiple TDP-43 binding sites if we randomized the order of genes ( Supplementary Fig. 4a ), if we ordered them by their expression levels (RPKM) in either treatment ( Supplementary Fig. 4b,c) , or if the Argonaute-binding sites were plotted on genes ranked by their expression pattern on TDP-43 depletion ( Supplementary Fig. 4d ). Furthermore, this trend was significant for TDP-43 clusters found in introns ( Fig. 3a) , but not in exons, 5′ or 3′ UTRs ( Supplementary Fig. 4e-g ).
To address whether TDP-43 binding enrichment in the downregulated genes could be attributed to intron size, we performed the same analysis on the ranked list, but calculated total (Fig. 3a) or mean ( Supplementary Fig. 4h ) intron size instead of cluster counts. We found that the most downregulated genes after TDP-43 reduction had exceptionally long introns that were more than sixfold longer (average of 28,707 bp; median length of 11,786 bp) than unaffected or upregulated genes (average of 4,532 bp, median length of 2,273 bp, on the survival of the animals. Mice were killed after 2 weeks and total RNA and protein from striata were isolated (Fig. 2a) . Samples treated with TDP-43 ASO showed a significant and reproducible reduction of TDP-43 RNA and protein to approximately 20% of normal levels when compared with controls (P < 3 × 10 -5 ; Fig. 2b) .
To explore the effects of TDP-43 downregulation on its target RNAs, we converted poly-A-enriched RNAs from four biological replicates of TDP-43 or control ASO-treated, as well as three saline-treated animals, to cDNAs and sequenced them in a strandspecific manner 22 , yielding an average of >25 million 72-bp reads per library. The number of mapped reads per kilobase of exon, per million mapped reads (RPKM) for each annotated protein-coding gene was determined to establish a metric of normalized gene expression 12 .
Hierarchical clustering of gene expression values for the independent samples revealed high correlation (R 2 = 0.96) between biological replicates of each condition (TDP-43 and control ASO/saline) ( Supplementary Fig. 3a) . Notably, all control ASO-treated samples were clustered together, as were the samples from TDP-43 ASO-treated animals, consistent with TDP-43 reduction having an appreciable effect on regulation of gene expression.
Reads of each treatment group were combined, yielding greater than 100 million uniquely mapped reads per condition (Fig. 2c) . Approximately 70% (11,852) of annotated protein-coding genes in mouse satisfied at least 1 RPKM in either condition. Statistical comparison revealed that 362 genes were significantly upregulated and 239 downregulated on reduction of TDP-43 protein (P < 0.05; Fig. 2d and Supplementary Tables 1 and 2). We found that TDP-43 itself was downregulated by RPKM analysis to 20% of the levels in control treatments, consistent with quantitative RT-PCR (qRT-PCR) measurements (Fig. 2b) . RNAs unique to neurons (including doublecortin, the neuron-specific beta-tubulin and choline O-acetyl transferase (Chat)) or glia (including glial fibrillary acidic protein, myelin binding protein, Glt1 and Mag) were highly represented in the RNA-seq data, confirming assessment of RNA levels in multiple cell types, as expected.
Of the set of ~242 literature-curated murine noncoding RNAs 23 , expression of 4 increased and expression of 55 decreased by more than twofold on TDP-43 depletion (P < 10 −5 ; Supplementary Table 3) . Malat1/Neat2, Xist, Rian and Meg3 are noncoding RNA examples that were both decreased (Fig. 2e,f) and bound by TDP-43, consistent with TDP-43 having a direct role in regulating their expression.
TDP-43 binding to long pre-mRNAs sustains their levels RNA-seq and CLIP-seq datasets were integrated by first ranking all 11,852 expressed genes by their degree of change on TDP-43 reduction compared with control treatment. For each group of 100 consecutively ranked genes (starting from the most upregulated gene), we determined the mean number of TDP-43 clusters. No enrichment in TDP-43 clusters in the upregulated genes was identified, indicating that their upregulation was likely an indirect consequence of TDP-43 loss. (a) Correlation between RNA-seq and CLIP-seq data. Genes were ranked on their degree of regulation after TDP-43 depletion (x axis) and the mean number of intronic CLIP clusters found in the next 100 genes from the ranked list were plotted (y axis, green line). Similarly, the mean total intron length for the next 100 genes was plotted (y axis, red line). The cluster count for each upregulated gene (red dots) and each downregulated gene (green dots) was plotted using the same ordering (inset). (b) qRT-PCR for selected downregulated genes with long introns (except for Chat) revealed a significant reduction of all transcripts when compared with controls (P < 8 × 10 −3 ). Error bars represent s.d. calculated in each group for 3-5 biological replicates. (c) Cumulative distribution plots comparing exon length (left) or intron length (middle) across mouse brain tissue-enriched genes (388 genes) and non-brain tissue-enriched genes (15,153 genes). Genes enriched in brain had significantly longer median intron length compared with genes not enriched in brain (right, solid red line and black lines, P < 6.2 × 10 −6 by two-sample Kolmogorov Smirnov goodness-of-fit hypothesis test), whereas a random subset of 388 genes showed no difference in intron length (dashed lines). Similar analysis across human brain tissue-enriched genes (387 genes) and non-brain tissue-enriched genes (17,985 genes) also showed significantly longer introns in brain enriched genes (solid red and black lines, P < 5.3 × 10 −6 ), whereas a random subset of 387 genes showed no difference in intron length (dashed lines). Median intron length (nt)
Mouse introns P < 6 x 10 -6 a r t i c l e s molecules neurexin 1 and 3 (Nrxn1, Nrxn3) and neuroligin 1 (Nlgn1).
We analyzed a compendium of expression array data from different mouse organs and human tissues and found that genes preferentially expressed in brain have significantly longer introns (P < 6 × 10 −6 ), but not exons (Fig. 3c) . The length of these genes was not correlated with the size of the respective proteins and the prevalence of long introns was largely conserved between the corresponding mouse and human genes. Although binding of TDP-43 in long introns can be explained by the increased likelihood to contain UG repeats, the conservation through evolution of this particular gene structure ( Supplementary  Fig. 7 ) suggests that these exceptionally long introns contain important regulatory elements.
To validate the RNA-seq results, we analyzed a selection of brainenriched TDP-43 targets containing long introns. Genome browser views of neurexin 3 (Nrxn3), Parkin 2 (Park2), neuroligin 1 (Nlgn1), fibroblast growth factor 14 (Fgf14), potassium voltage-gated channel subfamily D member 2 (Kcnd2), calcium-dependent secretion activator (Cadps) and ephrin-A5 (Efna5) revealed a scattered distribution of multiple TDP-43-binding sites across the full length of the pre-mRNA (Supplementary Fig. 7a) , consistent with the results of the global analysis (Fig. 3a) . qRT-PCR verified the TDP-43-dependent reduction of all the long transcripts that we tested (Fig. 3b) . Chat had a median intron size of <10 kb, with TDP-43 clusters restricted to a single intronic site (Supplementary Fig. 7a) . Nevertheless, qRT-PCR confirmed the RNA-seq result of a significant reduction in Chat levels after TDP-43 depletion (P = 0.005; Fig. 3b) .
Only 18% of the upregulated genes were direct targets of TDP-43 ( Table 1 ) and gene ontology analysis revealed an enrichment for genes involved in the inflammatory response ( Table 2 ), suggesting that their differential expression is an indirect consequence of TDP-43 loss. However, of the 66 upregulated RNAs that contained CLIPseq clusters, 29% harbored TDP-43-binding site(s) in their 3′ UTR, a percentage that is twofold higher than that of downregulated genes (Supplementary Fig. 8 ). This suggests that TDP-43 represses gene expression when bound to 3′ UTRs. P < 4 × 10 −18 by t test). Again, this correlation of downregulation with intron size was not observed for any of the control conditions mentioned above (Supplementary Fig. 4a-g) . Indeed, the enrichment of TDP-43 binding can be largely attributed to intron size differences, as the number of TDP-43-binding sites per kilobase of intron length (cluster density; Supplementary Fig. 4i ) was only slightly increased (P < 0.022) for downregulated versus unaffected or upregulated genes (0.072 sites per kb downregulated genes, 0.059 sites per kb other genes). Dividing all mouse protein-coding genes into four groups on the basis of mean intron length (<1 kb, 1-10 kb, 10-100 kb and >100 kb) confirmed that the fraction of TDP-43 targets increased (from 20% to 100%) with intron size (Table 1) . Indeed, 83% of genes that contained average intron lengths of 10-100 kb and all 26 genes that contained >100-kb-long introns were direct targets of TDP-43.
A highly significant fraction (74%) of all downregulated genes were direct targets of TDP-43 in comparison with genes that were unchanged (52%, P < 0.001) or upregulated (18%, P < 10 −17 ) on TDP-43 depletion. Notably, all 19 downregulated genes with >100-kb-long introns were direct TDP-43 targets. In strong contrast, no genes in the same intron length category were upregulated on TDP-43 depletion and only 30% of upregulated genes with 10-100-kb-long introns were TDP-43 targets ( Table 1) . The crucial role of TDP-43 in maintaining the mRNA abundance of long intron-containing genes was also reflected by the downregulation after TDP-43 depletion of ~10% of genes with >10-kblong introns, the large majority (123 of 128, 96%) of which are direct TDP-43 targets.
Gene ontology analysis showed that TDP-43 targets whose expression was downregulated after TDP-43 depletion were highly enriched for synaptic activity and function ( Supplementary Figs. 5 and 6 and Supplementary Table 4) . Notably, several genes with long introns targeted by TDP-43 have crucial roles in synaptic function and have been implicated in neurological diseases, such as subunit 2A of the NMDA receptor (Grin2a), the ionotropic glutamate receptor 6 (Grik2/GluR6), the calcium-activated potassium channel alpha (Kcnma1), the voltagedependent calcium channel (Cacna1c), and the synaptic cell-adhesion Examples of the most significantly enriched Gene Ontology (GO) terms in the list of up-or downregulated genes on TDP-43 knockdown, as annotated. Downregulated genes, the majority of which were direct targets of TDP-43, were enriched for synaptic activity and function. In contrast, upregulated genes, most of which were not bound by TDP-43, encoded primarily inflammatory and immune response-related proteins. The P value indicated was corrected for multiple testing using the Benjamini-Hochberg method.
As an independent method of identifying TDP-43-regulated exons, RNAs from the same ASO-treated animals were analyzed on customdesigned splicing-sensitive Affymetrix microarrays 27 . Using a conservative statistical cutoff, we detected 779 alternatively spliced events that significantly changed on TDP-43 depletion (Supplementary Fig. 9) . Notably, included (P < 10 −3 ), but not excluded, exons (P < 0.3) were significantly enriched for TDP-43 binding (~1.8-fold and ~1.3-fold, respectively) when compared with the unchanged exons on the microarray (Fig. 4a) , similar to the trend seen by RNA-seq. The combined RNA-seq and splicing-sensitive microarray data defined a set of 512 alternatively spliced cassette exons whose splicing was affected by loss of TDP-43. The majority of human orthologs of these murine exons (85% of those with excluded and 57% with included exons) had prior EST/mRNA evidence for alternative splicing (Fig. 4c) .
Semi-quantitative RT-PCR on selected RNAs validated splicing alterations with more inclusion or exclusion after TDP-43 reduction (Fig. 4d  and Supplementary Fig. 10) . Notably, varying the extent of TDP-43 downregulation (between 40-80%) correlated with the magnitude of splicing changes (Supplementary Fig. 11) . However, the majority of TDP-43 mediates alternative splicing of its mRNA targets Although TDP-43-binding sites were enriched in distal introns (Fig. 1f) , 11% (21,041 out of 190,161) of all mouse exons, including both constitutive and alternative exons, contained TDP-43-binding site(s) in a 2-kb window extending from the 5′ and 3′ exon-intron boundaries (Fig. 4a) . Compared with all exons, TDP-43 clusters were significantly enriched (P < 8 × 10 −3 ) around exons with transcript evidence for either alternative inclusion or exclusion (that is, cassette exons). Of the 8,637 known mouse cassette exons, 15.1% contained TDP-43-binding sites in the exon or intron within 2 kb of the splice sites. A splice index score for all exons, a measure similar to the 'percent spliced in' (or ψ) metric 24 , was determined by the number of reads that mapped on exons as well as reads that mapped at exon junctions (Fig. 4b) . This analysis resulted in the identification of 203 cassette exons that were differentially included (93) or excluded (110) (P < 0.01) when TDP-43 was depleted. Notably, sortilin 1, the gene encoding the receptor for progranulin 25, 26 , had the highest splice index score, with exon 18 exclusion requiring TDP-43 (Fig. 4b) . Included exons (P < 3 × 10 −6 ) and, to a lesser extent, excluded exons (P < 2 × 10 −3 ) identified by RNA-seq were significantly enriched (~2.7-fold and ~2.0-fold, respectively) for TDP-43 binding when compared to all mouse exons (Fig. 4a) . Only 33% of RNA-seq-verified TDP-43-regulated cassette exons had previous expressed sequence tag (EST)/mRNA evidence for alternative splicing, demonstrating that our approach identified previously unknown alternative splicing events. Fig. 12a ). Both unspliced and spliced 3′ UTRs were determined to be present in brain RNAs from mouse and human CNSs (Supplementary Fig. 12a ). Both variants, as well as an unaltered luciferase reporter, were transfected into HeLa cells along with plasmids driving either increased TDP-43 expression or red fluorescent protein (RFP; Supplementary Fig. 12b ). Increased levels of TDP-43 protein led to a significant reduction of luciferase produced from the gene carrying the long, intron-containing TDP-43 3′ UTR when compared with the short or unrelated 3′ UTR (P < 10 -4 ; Fig. 5f ). Moreover, co-transfection of the reporters with siRNAs targeting UPF1 (Supplementary Fig. 12c ), an essential component that marks an NMD substrate for degradation 32 , enhanced luciferase produced by the intron-containing 3′ UTR by ~1.5-fold, indicating that UPF1-dependent degradation of this mRNA occurred (Fig. 5f) . Lastly, the endogenous spliced isoform 3 of TDP-43 Table 5 ).
TDP-43 autoregulation through binding on its 3′ UTR
We found TDP-43-binding sites in an alternatively spliced intron in the 3′ UTR of the TDP-43 pre-mRNA (Fig. 5a ). This binding does not coincide with a long stretch of UG repeats, suggesting a lower strength of binding ( Supplementary Fig. 2a ), consistent with a recent report 28 . TDP-43 mRNAs spliced at this site ( Fig. 5a ) are predicted to be substrates for nonsense-mediated RNA decay (NMD), a process that targets mRNAs for degradation when exon-junction complexes (EJCs) deposited during splicing, located 3′ of the stop codon, are not displaced during the pioneer round of translation 29 . In contrast, TDP-43 mRNAs with an unspliced 3′ UTR would not have such a premature termination codon and should escape NMD. This TDP-43 binding implies autoregulatory mechanisms reminiscent to those reported for other RNA-binding proteins 30, 31 . Indeed, expression in mice of a TDP-43-encoding transgene without the regulatory 3′ UTR (E.S., S.-C.L. and D.W.C., unpublished observations) led to significant reduction of endogenous TDP-43 mRNA and protein (P < 4 × 10 -3 ; Fig. 5b,c) in the CNS.
To identify the molecular basis of this mechanism, we generated HeLa cells in which GFPmyc-TDP-43-HA mRNA lacking introns and 3′ UTR was transcribed from a single copy, tetracycline-inducible transgene inserted at a predefined locus by site-directed (Flp) recombinase 16 . After 24 or 48 h of GFP-myc-TDP-43-HA induction, a substantial reduction of endogenous TDP-43 protein was observed, accompanied by accumulation of a shorter, ~30-kDa product (Fig. 5d) recognized by four different TDP-43-specific antibodies. Although this ~30-kDa band could be derived from the transgene encoding TDP-43, it was not recognized by antibodies to myc or HA and its size is compatible with the endogenous TDP-43 isoform 3. Using qRT-PCR with primers spanning the exon junctions of TDP-43 isoform 3, we found a ~100-fold increase of the spliced isoform 3 on overexpression of GFP-myc-TDP-43-HA protein (Fig. 5e) .
To test whether TDP-43 drives splicing of its pre-mRNA through binding to its 3′ UTR, we cloned a long unspliced version (containing the TDP-43-binding sites) and a short spliced version (without TDP-43-binding a r t i c l e s DISCUSSION TDP-43 is a central component in the pathogenesis of an ever-increasing list of neurodegenerative conditions. We created a genome-wide RNA map of >39,000 TDP-43-binding sites in the mouse transcriptome and determined that levels of 601 mRNAs and splicing patterns of 965 mRNAs were altered following TDP-43 reduction in the adult nervous system. Thus, although earlier efforts have implicated TDP-43 as a splicing regulator of a few candidate genes 20, 43, 44 , our RNA-seq and microarray results establish that TDP-43 regulates the largest set (512) of cassette exons thus far reported, demonstrating its broad role in was increased, not only on elevated TDP-43 expression (by transient transfection), but also on blocking of NMD, with a synergistic effect in the combined conditions (Fig. 5g) .
TDP-43 regulates expression of disease-related transcripts TDP-43 protein bound and directly regulated a variety of transcripts involved in neurological diseases (Supplementary Table 6 and Supplementary Figs. 8 and 13) , including Fus/Tls and Grn (Fig. 6) , which encode FUS/TLS and progranulin, mutations in which cause ALS 10, 11 or FTLD 33, 34 , respectively. TDP-43 bound to the 3′ UTR of Fus/Tls mRNA and to introns 6 and 7, all of which are highly conserved between mammalian species (Fig. 6a) . Gene annotation and the presence of RNA-seq reads in these introns were consistent with either an alternative 3′ UTR or intron retention. Fus/Tls mRNA and protein were reduced to approximately 40% of their normal levels (Fig. 6b,c) .
Progranulin mRNA, on the other hand, was markedly increased by ~3-6-fold compared with controls ( Fig. 6d,e) . CLIP-seq data also confirmed TDP-43 binding to two RNAs that were previously reported to be associated with TDP-43: histone deacetylase 6 (Hdac6) 35 and low-molecular weight neurofilament subunit (Nefl) 36 . Our RNA-seq data indicate that HDAC6, which functions to promote the degradation of polyubiquitinated proteins, was reduced on TDP-43 depletion (Supplementary Fig. 14a,b) , albeit to a lesser degree in vivo than previously reported in cell culture 35 . It has been known for many years that Nefl mRNA levels are reduced in degenerating motor neurons from individuals with ALS 37 . We identified TDP-43 clusters in the 3′ UTR of Nefl (Supplementary Fig. 14c ). In addition, RNA-seq data confirmed that the mouse Nefl 3′ UTR was longer than annotated and Nefl mRNA levels were slightly reduced on TDP-43 depletion ( Supplementary  Fig. 14d ). Multiple TDP-43-binding sites were also present in the premRNA from the Mapt gene encoding tau, whose mutation or altered splicing of exon 10 has been implicated in FTD 38 . However, neither the levels nor the splicing pattern of Mapt RNA were affected by TDP-43 depletion (Supplementary Table 6 ). Moreover, we identified multiple TDP-43 intronic binding sites in the Hdh transcript ( Supplementary  Fig. 13 ), which encodes huntingtin, the protein whose polyglutamine expansion causes Huntington's disease in humans 39 , accompanied by cytoplasmic TDP-43 accumulations 40 . Moreover, Hdh levels were decreased in mouse brain on TDP-43 depletion (Supplementary Table 6 ). In contrast, we found no evidence for direct binding or TDP-43 regulation of the Sod1 transcript (Supplementary Table 6) , whose aberrant splicing in familial ALS cases 41, 42 has raised the possibility that SOD1 missplicing may be involved in the pathogenesis of sporadic ALS. 
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
alternative splicing regulation. We also found that TDP-43 was required for maintenance of 42 non-overlapping, noncoding RNAs. These findings also provide a direct test for how the nuclear loss of TDP-43 widely reported in the remaining motor neurons in ALS autopsy samples 1 may contribute to neuronal dysfunction, independent of potential damage from TDP-43 aggregates. The results of our experiments using in vivo reduction of TDP-43 coupled with RNA sequencing indicate that TDP-43 is crucial for sustaining levels of 239 mRNAs, including those encoding synaptic proteins, the choline acetyltransferase, and the disease-related proteins FUS/TLS and progranulin. A substantial proportion of these pre-mRNAs are directly bound by TDP-43 at multiple sites in exceptionally long introns, a feature that we found most prominently in brain-enriched transcripts (Fig. 3) , thereby identifying one component of neuronal vulnerability from TDP-43 loss.
A plausible model for the role of TDP-43 in sustaining the levels of mRNAs derived from long pre-mRNAs is that TDP-43 binding in long introns prevents unproductive splicing events that would introduce premature stop codons and thereby promote RNA degradation. Our results thus identify a previously unknown conserved role for TDP-43 in regulating a subset of these long intron-containing brain-enriched genes. None of our evidence eliminates the possibility that TDP-43 affects RNA levels by additional mechanisms, such as through transcription regulation or by facilitation of RNA polymerase elongation, similar to what has been shown for another splicing regulator, SC35 (ref. 45) .
FUS/TLS is another RNA-binding protein whose mutation causes ALS 10, 11 and, in some rare cases, FTLD-U. Similar to TDP-43, FUS/ TLS aggregation has been observed in different neurodegenerative conditions, including Huntington's disease and spinocerebellar ataxia (reviewed in ref. 3) . We have now shown that Fus/Tls mRNA is a direct target of TDP-43 and its level is reduced on TDP-43 depletion (Fig. 6) , thereby identifying a previously unknown FUS/TLS dependency on TDP-43. The latter is also true for two additional disease-relevant proteins, progranulin and its proposed receptor sortilin. Progranulin levels were sharply increased on TDP-43 reduction and splicing of sortilin was altered. In fact, TDP-43 directly binds and regulates the levels and splicing patterns of transcripts implicated in various neurologic diseases 46 (Supplementary Table 6 and Supplementary Fig. 13 ), consistent with a broad role of TDP-43 in these conditions 3 .
Finally, in contrast with a recent study that reported an autoregulatory mechanism for TDP-43 that is independent of pre-mRNA splicing 28 , our results indicate that TDP-43 acts as a splicing regulator to reduce its own expression level by binding to the 3′ UTR of its own pre-mRNA. Although there may be additional mechanisms beyond NMD 28 , we found that TDP-43 enhanced splicing of an alternative intron in its own 3′ UTR, thereby autoregulating its levels through a mechanism that involves splicing-dependent RNA degradation by NMD (Fig. 5) . TDP-43 autoregulation occurs in the mammalian CNS, as seen by a significant reduction of endogenous TDP-43 mRNA and protein in response to the expression of a TDP-43 transgene lacking the regulatory intron, as we found and others have reported previously 47, 48 . Both spliced and unspliced TDP-43 RNAs were found in human and mouse brain, consistent with autoregulation at normal TDP-43 levels that substantially attenuates TDP-43 synthesis through production of unstable, spliced RNA.
TDP-43-dependent splicing of its 3′ UTR intron as a key component of a TDP-43 autoregulatory loop could participate in a feedforward mechanism enhancing the cytoplasmic TDP-43 aggregates that are hallmarks of familial and sporadic ALS. Following an initiating insult (for example, one that traps some TDP-43 in initial cytoplasmic aggregates), the reduction in nuclear TDP-43 levels would decrease splicing of its 3′ UTR, which would in turn produce an elevated pool of stable TDP-43 mRNA. Repeated translation of that TDP-43 mRNA would increase Functional annotation analysis. We used the Database for Annotation, Visualization and Integrated Discovery (DAVID Bioinformatic Resources 6.7; http://david.abcc.ncifcrf.gov/). For all genes downregulated or upregulated on TDP-43 depletion, a background corresponding to all genes expressed in brain was used.
Transcriptome and splicing analysis. Strand-specific RNA-seq reads each from control oligonucleotide, saline-and TDP-43 oligonucleotide-treated animals were generated and ~50% mapped uniquely to our annotated gene structure database using the bowtie short-read alignment software (version 0.12.2, with parameters -m 5 -k 5 --best --un --max -f) incorporating the base-calling quality of the reads. To eliminate redundancies created by PCR amplification, all reads with identical sequence were considered single reads. The expression value of each gene was computed by RPKM. Each RNA-seq sample was summarized by a vector of RPKM values for every gene and pair-wise correlation coefficients were calculated for all replicates using a linear least-squares regression against the log RPKM vectors. Hierarchical clustering revealed that the three treated conditions clustered into similar groups. The reads in each condition were combined to identify genes that were significantly up-and downregulated on TDP-43 depletion. Local mean and s.d. were calculated for the nearest 1,000 genes, as determined by log average RPKM values between knockdown and control and a local Z score was defined. The resulting Z scores were used to assign significantly changed genes (Z > 2 upregulated, Z < -2 downregulated), as well as ranking the entire gene list for relative expression changes. Specific parameters, such as intron length or TDP-43-binding sites, were plotted for the next 100 genes.
Exons with canonical splice signals (GT-AG, AT-AC, GC-AG) were retained, resulting in a total of 190,161 exons. For each protein-coding gene, the 50 bases at the 3′ end of each exon were concatenated with the 50 bases at the 5′ end of the downstream exon producing 1,827,013 splice junctions. An equal number of 'impossible' junctions was generated by joining the 50-base exon junction sequences in reverse order. To identify differentially regulated alternative cassette exons, we employed a modification of a published method 24 . In short, the read count supporting inclusion of the exon (overlapping the cassette exon and splice junctions including the exon) were compared with the read count supporting exclusion of the exon (overlapping the splice junction of the upstream and downstream exon. For a splice junction read to be enumerated, we required that at least 18 nucleotides of the read aligned and 5 bases of the read extended over the splice junction with no mismatches 5 bases around the splice junction. For the TDP-43 and control ASOs comparison, we constructed a 2 × 2 contingency table using of the counts of the reads supporting the inclusion and exclusion of the exon, in two conditions. Every cell in the 2 × 2 table had to contain at least five counts for a χ 2 statistic to be computed. At P < 0.01, 110 excluded and 93 included single cassette exons were detected to be differentially regulated by TDP-43. As an estimate of false discovery, we observed that ~20 single cassette exons were detected by using the impossible junction database.
Pre-mRNA features and tissue-specificity analysis. Affymetrix microarray data representing 61 mouse tissues were downloaded from the Gene Expression Omibus repository (http://www.ncbi.nih.gov/geo) under accession number GSE1133 (ref. 50). Probes on the microarrays were cross-referenced to 15,541 genes in our database using files downloaded from the UCSC Genome Browser (knownToGnf1m and knownToGnfAtlas2). The expression value for each gene was represented by the average value of the two replicate microarray experiments for each tissue. To identify genes enriched in brain, we grouped 13 tissues as 'brain' (substantia nigra, hypothalamus, preoptic, frontal cortex, cerebral cortex, amygdala, dorsal striatum, hippocampus, olfactory bulb, cerebellum, trigeminal, dorsal root ganglia, pituitary) and the remaining 44 tissues as 'non-brain' , excluding the five embryonic tissues (embryonic days 10.5, 9.5, 8.5, 7.5 and 6.5).
For each gene, the t statistic was computed as t = ( )
